Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record.

Short‐term adverse effects of 5‐aminosalicylic acid agents in the treatment of ulcerative colitis

Loftus, E. V., Kane, S. V., Bjorkman, D.·2004·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Aim: To determine whether there is a difference in short‐term adverse events in patients with ulcerative colitis treated with mesalazine, olsalazine or balsalazide. Methods: MEDLINE was searched for articles published until 2002. Randomized trials of oral mesalazine, olsalazine or balsalazide for the treatment of active disease or the maintenance of remission were included. Outcomes of interest were the frequencies of patients experiencing adverse events and those withdrawn due to adverse events. Results: Forty‐six trials were included. One study of mesalazine vs. sulfasalazine for active colitis showed significantly fewer patients with adverse events with mesalazine. Both balsalazide vs. sulfasalazine studies for active disease showed significantly fewer withdrawals with balsalazide. One trial of balsalazide vs. sulfasalazine for maintenance showed significantly fewer patients with adverse events with balsalazide. Otherwise, no significant differences in safety outcomes were noted. Conclusion: All three 5‐aminosalicylic acid agents are safe in the short term. In mesalazine‐treated patients, the frequencies of adverse events or withdrawals due to adverse events were comparable with those in placebo‐treated patients and lower than those in sulfasalazine‐treated patients. Overall, adverse events or withdrawals were not significantly more frequent with olsalazine than with placebo or sulfasalazine. Adverse events and study withdrawals on balsalazide were less frequent than those on sulfasalazine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.0269-2813.2004.01827.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 184

Metadata

Authors
Loftus, E. V., Kane, S. V., & Bjorkman, D.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2004-01
Volume
19
Issue
2
Pages
179-189
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2023129837
Cited by
184
References
0
FWCI
6.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short‐term adverse effects of 5‐aminosalicylic acid agents in the treatment of ulcerative colitis. https://app.cochat.ai/papers/10.1111/j.0269-2813.2004.01827.x
The paper
Loftus, E. V., Kane, S. V., & Bjorkman, D. (2004). Short‐term adverse effects of 5‐aminosalicylic acid agents in the treatment of ulcerative colitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.0269-2813.2004.01827.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.